Challenge Competition: Announcement of AHRQ Challenge on Integrating Healthcare System Data With Systematic Review Findings, 58350-58353 [2022-20703]
Download as PDF
58350
Federal Register / Vol. 87, No. 185 / Monday, September 26, 2022 / Notices
2021, in response to a recommendation
of the Depository Library Council (DLC),
GPO Director Hugh N. Halpern
established a Task Force to study the
feasibility of an all-digital FDLP. The
23-member Task Force has
representation from the DLC, Federal
depository libraries (FDLs) of different
types and sizes, library association
representatives, Federal agencies, and
GPO. The Task Force has been working
throughout 2022–10 investigate whether
an all-digital FDLP is possible, and if so,
to define the scope of an all-digital
depository program and make
recommendations as to how to
implement and operate such a program.
The Task Force’s purview included an
examination of the current landscape in
FDLs, of FDLP-related operations at the
GPO, and of the dissemination of
publications by Federal agencies. The
draft report of the Task Force is now
available for public comment at https://
www.fdlp.gov/.
DATES: Comments must be received by
October 14, 2022.
ADDRESSES: You may submit comments
via the comment form available at
https://www.fdlp.gov/.
FOR FURTHER INFORMATION CONTACT:
Kristene Blake, (202) 262–3397, or
FDLPtaskforce@gpo.gov.
Hugh Nathanial Halpern,
Director, U.S. Government Publishing Office.
[FR Doc. 2022–20383 Filed 9–23–22; 8:45 am]
BILLING CODE 1520–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Challenge Competition:
Announcement of AHRQ Challenge on
Integrating Healthcare System Data
With Systematic Review Findings
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is
announcing a challenge competition to
explore the resources and infrastructure
needed to integrate real-world data from
healthcare systems into systematic
review findings. This healthcare
systems data can augment study
findings synthesized in systematic
reviews in a number of ways, including
by filling evidence gaps identified in the
systematic review to strengthen the
available evidence, and by examining
the applicability of systematic review
SUMMARY:
VerDate Sep<11>2014
16:43 Sep 23, 2022
Jkt 256001
findings to real-world populations,
including population subgroups not
examined in published studies.
Ultimately, this work will help AHRQ
understand if and how sources of data
and information outside of traditional
systematic reviews, particularly from
healthcare systems themselves, could be
used alongside systematic reviews to
improve healthcare decision making,
healthcare delivery and potentially
patient outcomes. This challenge
competition will start on (September 26,
2022) and will be completed in two
phases, with cash prizes awarded at the
end of Phase 2 to all of those proceeding
to Phase 2 and to the winners of Phase
2. The winner and runner-up from
Phase 2 will be posted on the AHRQ
website.
DATES: Phase 1 Submission Deadline on
January 9, 2023 and Phase 2 Submission
Deadline on July 10, 2023.
ADDRESSES: Submit your responses
electronically via: https://
www.challenge.gov/?challenge=ahrqchallenge-on-integrating-healthcaresystem-data-with-systematic-reviewfindings.
FOR FURTHER INFORMATION CONTACT:
Suchitra Iyer, Director, Technology
Assessment Program; Email:
AHRQChallenges@ahrq.hhs.gov,
Telephone: 301–427–1550.
SUPPLEMENTARY INFORMATION:
Problem Statement
The Agency for Healthcare Research
and Quality (AHRQ), U.S. Department
of Health and Human Services (HHS), is
announcing a challenge competition to
explore the feasibility, resources and
infrastructure needed to integrate real
world data from healthcare systems into
systematic review findings. The
statutory authority for this challenge
competition is Section 105 of the
America COMPETES Reauthorization
Act of 2010.
AHRQ’s Evidence-based Practice
Center (EPC) Program produces
systematic reviews which synthesize
information from the peer reviewed
literature and provide the state of the
science on available healthcare
technologies (such as pharmaceuticals
and medical devices) as well as
healthcare delivery strategies. The
process of creating these reviews is
stakeholder driven, methodologically
rigorous, and transparent. Reviews are
used to inform healthcare decisions,
including recommendations in clinical
practice guidelines as well as national
coverage determinations by Medicare.
AHRQ also supports healthcare systems
in their efforts to improve the quality of
care and optimize patient outcomes;
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
systematic reviews are scoped to
address issues of priority to healthcare
systems. Yet, due to limitations in the
literature base, EPC systematic reviews
may be inconclusive or only represent a
narrow patient population, making it
difficult to generalize or implement the
findings within heterogeneous
healthcare systems.
Systematic reviews may also lack
contextual details that can inform
successful implementation. Improving
healthcare delivery (and thus patient
outcomes) often entails addressing
issues beyond the benefits or harms of
an intervention, traditionally the
objective of a systematic review.
Traditional reviews may not explain
gaps in uptake or use of a clinical
service and questions about how best to
implement a given clinical service (e.g.,
details around implementation of a
service or intervention).
A recent EPC Program methods report
(https://effectivehealthcare.ahrq.gov/
products/unpublished-health-data/
methods-report) articulates specific
scenarios with examples of where
healthcare system data may most
effectively complement systematic
reviews (i.e., to improve the strength,
applicability, and implementation of
evidence). In one example, investigators
at the Mayo Clinic found that published
evidence on outcomes following total
pancreatectomy was sparse, so they
supplemented a meta-analysis of
published studies with their own
unpublished healthcare system data,
which more than doubled the sample
size and improved the strength of
evidence available (https://
pubmed.ncbi.nlm.nih.gov/20681992/).
In another instance, secondary
analyses of Veterans Affairs (VA) data
(https://pubmed.ncbi.nlm.nih.gov/
35810550/) confirmed the applicability
to the VA of findings from a published
systematic review (https://
www.hsrd.research.va.gov/publications/
esp/robot-gen-surg.cfm).
The recent EPC methods report also
outlines important limitations and
considerations when using unpublished
healthcare system data alongside
systematic reviews, such as relevant
limitations in data quality. However, the
report did not address the necessary
resources, skills, partnerships, and
processes required to utilize healthcare
system data alongside systematic
reviews to strengthen the actionability
of systematic reviews.
This Challenge therefore invites
applicants to conduct an analyses of
healthcare system data to supplement
an existing AHRQ EPC Program
systematic review. This will help AHRQ
understand if and how sources of data
E:\FR\FM\26SEN1.SGM
26SEN1
Federal Register / Vol. 87, No. 185 / Monday, September 26, 2022 / Notices
and information outside of traditional
systematic reviews, particularly from
healthcare systems themselves, could be
used alongside systematic reviews to
improve decision making, healthcare
delivery, and potentially patient
outcomes.
Challenge Goal
The AHRQ EPC Program is interested
in learning how analysis of real-world
data collected by healthcare systems can
be used in conjunction with findings
from an AHRQ systematic review to
inform healthcare decision-making in
the context of a specific local setting.
The goal of this challenge is to
explore and determine the feasibility,
resources, and infrastructure needed to
incorporate unpublished healthcare
system data into systematic review
findings. Ideally, these data will enable
the healthcare system to make decisions
about which practices to incorporate
locally and how to overcome barriers to
implement the evidence to improve
clinical practice, healthcare system
operations and, potentially, health
outcomes. The winner and runner-up
from Phase 2 will be posted on the
AHRQ website.
Challenge Design
• All evidence reports (systematic
reviews, rapid reviews, and technical
briefs) published on the AHRQ website
since January 2018 (https://effective
healthcare.ahrq.gov/about) may be
considered for this Challenge.
• Healthcare systems and other
provider groups interested in
implementing evidence into practice at
their sites may apply.
• An organization may choose to
address no more than 2 systematic
reviews, submitting a separate proposal
for each review.
• Teams should have expertise in the
clinical topic, evidence-based practice,
data analysis, and quality improvement.
This Challenge consists of two phases:
Phase 1: Proposal
Elicit written proposals on a topic for
which an AHRQ evidence report
(systematic review, rapid review or
technical brief) has been published
since January 2018 (https://effective
healthcare.ahrq.gov/about) and that is
relevant to a dilemma in the applicant’s
healthcare system. Each proposal is to
be written in the form of a narrative
that:
1. Explicitly states the rationale (i.e.,
addressing evidence gaps to strengthen
available evidence, examining
applicability of findings to real-world
patients) to complement findings from
an EPC report with analysis of health
VerDate Sep<11>2014
16:43 Sep 23, 2022
Jkt 256001
system data, including a discussion of
possible limitations of the analysis.
2. Develops and describes an analytic
plan for use of healthcare system data
[EHR data from an individual healthcare
system or networks of healthcare
systems (for example, PCORnet, Epic’s
Cosmos, etc.)].
3. Provides an approach for decisionmaking based on the results of the data
analysis and the evidence report, and an
evaluation of the decision-making
process and results.
4. Describes potential challenges,
barriers, and strategies to successfully
complete the analysis.
5. Lists team members, their role, area
of expertise and hours on project.
A total of 5 proposals will be selected
as winners for Phase 1.
Phase 2: Analyses
Healthcare systems selected as
winners in Phase 1 will be invited to
provide a written narrative that:
1. Includes a complete analysis of
internal real-world data and appraisal of
the analysis for risk of bias using a
formal tool such as the ROBINS I
(https://www.bmj.com/content/355/
bmj.i4919).
2. Specifies how the findings from
unpublished data support, refute, and/
or otherwise complement findings from
the published evidence examined in the
systematic review. If the unpublished
data conflicts with the AHRQ review’s
conclusions, discuss possible reasons
for the discrepancy [e.g., challenges
with internal validity of healthcare
system data analysis related to study
design and methods used, or challenges
with external validity with respect to
population sub-groups (gender, race/
ethnicity, multimorbidity) examined in
the healthcare system data].
3. Describes how the unpublished
data informed decision-making (e.g.,
adapt, adopt, abandon, prioritize).
4. Reports on solutions to any barriers
encountered to using healthcare system
data alongside a published evidence
review, including barriers with access to
healthcare system data, interoperability
of data sources, and data analysis.
5. Briefly describes potential
approaches to implement or
deimplement the evidence, including
use of clinical advisories, clinical
pathways, clinical decision support, or
any other method. The plan should
describe anticipated risks and barriers
and strategies for successful
implementation. Decisions made against
uptake should be justified.
Timeline and Prize Amounts
AHRQ is hosting this challenge as a
two-phase competition. All costs
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
58351
associated with developing and
submitting proposals as well as
conducting the analysis of real-world
data will be the responsibility of the
Challenge participant. Cash prizes will
be awarded only after the projects are
evaluated and determined acceptable at
the end of Phase 2.
Timeline
• September 26, 2022—Challenge
launch.
• January 9, 2023—Submissions for
Phase 1 (written proposals) are due.
AHRQ will complete the review of the
proposals within 6–8 weeks of closing
the announcement.
• March 10, 2023—AHRQ will
announce the Phase 1 winners. Phase 2
of the Challenge will commence once
the Phase 1 winners are announced and
notified by March 10, 2023. The AHRQ
team will schedule a live, virtual
technical assistance webinar with all
winners of Phase 1 to discuss scope of
content, accessibility/compliance with
Section 508, and address questions that
the winners may have.
• March 10, 2023—Phase 2
participants will have at least 120
calendar days from notification to
conduct and submit their analyses as
described in their proposal(s). The
deadline to submit the analysis is July
10, 2023.
• Fall 2023—The final winners of
Phase 2 of the competition will be
announced in October 2023.
Prize Amounts
The top five entries in phase one will
be invited to participate in Phase 2.
Upon completion of Phase 2, each of the
top five entries will each receive cash
awards of $50,000. Additionally, the
first-place winner from Phase 2 will be
awarded an additional $150,000 and the
runner-up will be awarded an
additional $100,000. The winner and
runner-up from Phase 2 will be posted
on the AHRQ website.
How To Enter the Challenge
Participants can register by visiting
the Challenge.gov website (https://
www.challenge.gov). Participants should
carefully review challenge information
and submission requirements on the
website, including the intellectual
property rules and assessment criteria.
Participants are encouraged to follow
the Challenge on Challenge.gov to
obtain any updates and reminders of
upcoming deadlines.
Submission Requirements
Phase 1
The submitted proposals must be
written in US English and submitted
E:\FR\FM\26SEN1.SGM
26SEN1
58352
Federal Register / Vol. 87, No. 185 / Monday, September 26, 2022 / Notices
using Challenge.gov no later than
January 9, 2023. Applicants or applicant
organizations shall submit no more than
2 proposals, and no proposal shall
describe more than one topic. Each
proposal will be no more than 2,000
words, double spaced, 11-point type
size, with 1-inch margins. Include in
proposals plans for meeting Section 508
accessibility standards.
Phase 2
Analyses shall be a journal articlestyle written narrative in U.S. English in
no more than 4,000 words and
submitted using the Challenge.gov
website no later than July 10, 2023.
Review Process
All submissions will be reviewed by
at least two subject matter experts from
within or outside the federal
government who will score the
proposals based on the assessment
criteria and provide a brief comment
about the submission. The scores/
comments on Phase 1 and Phase 2
submissions will be compiled, and a
ranked summary provided to AHRQ
staff. AHRQ will select winners based
on quantitative and qualitative
assessments.
Evaluation Criteria for Selecting
Winning Applications
Assessment Criteria for Phase 1
1. Approach (40 points)
Does the proposal sufficiently
describe:
a. the context and rationale for why
the EPC report has been chosen, and
how the analyses of unpublished data
will complement the findings from the
systematic review?
b. the data source and the analytic
approach? Does the described analytic
approach provide the right balance of
feasibility, rigor, and innovation for the
project?
2. Impact (40 points)
Does the proposal clearly and
concisely describe:
a. potential routes for uptake of
evidence within the healthcare system?
b. method to measure whether the
uptake will have an impact on
healthcare delivery, quality of care or
patient outcomes?
c. anticipated risks, barriers, and
strategies to successfully complete the
project?
3. Team (20 points)
Does the team have the right
combination of expertise to support the
proposed technical approach?
Compliance (pass/fail)—Does the
Phase 1 proposal adequately address
VerDate Sep<11>2014
16:43 Sep 23, 2022
Jkt 256001
required accessibility standards (Section
508)?
Assessment Criteria for Phase 2
Participants in Phase 2 may be
disqualified if their submitted analyses
deviate from their Phase 1winning
proposals.
1. Analysis (40 points)
a. Are the description and discussion
of the findings from the analysis
comprehensive?
b. To what degree is the alignment/
nonalignment between healthcare
system data, the AHRQ systematic
review, and the healthcare system’s
decision-making explained?
2. Description of the Process (40 points)
a. Are the risks, barriers, challenges
encountered, solutions, and required
infrastructure well described?
3. Future Plans (20 points)
a. Is the preliminary plan for
implementation and evaluation
appropriate and feasible?
Compliance (pass/fail)—Does the
Phase 1 proposal adequately address
required accessibility standards (Section
508)?
Eligibility Rules for Participating in the
Challenge
To be eligible under this Challenge,
an individual (whether participating
singly or in a group) or entity:
1. Shall have registered
(Challenge.gov) to participate in the
Challenge.
2. Shall have complied with the rules
set forth in this announcement for
participation in this Challenge.
3. Shall be incorporated and maintain
a primary place of business in the
United States (in the case of a private
entity), and in the case of an individual,
whether participating singly or in a
group, shall be a citizen or permanent
resident of the United States.
4. May not be a Federal entity or
Federal employee acting within the
scope of their employment. (All Federal
employees should consult with their
agency Ethics Official to determine
whether the federal ethics rules will
limit or prohibit the acceptance of a
prize).
5. May not be an employee of AHRQ
or any other company, organization, or
individual involved with the design,
production, execution, judging, or
distribution of the Challenge, or their
immediate family (spouse, parents and
step-parents, siblings and step-siblings,
and children and step-children), or
household members (people who share
the same residence at least 3 months out
of the year).
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
6. May not use Federal funds from a
grant to develop Challenge applications
unless consistent with the purpose of
the grant award.
7. May not use Federal funds from a
contract to develop Challenge
applications or to fund efforts in
support of a Challenge submission.
8. Shall not be deemed ineligible
because the individual or entity used
Federal facilities or consulted with
Federal employees during a competition
if the facilities and employees are made
equitably available to all individuals
and entities participating in the
competition.
9. Shall not be required to purchase
liability insurance as a condition of
participation in this competition.
Additional Rules of Participation
By participating in this Challenge,
each individual (whether participating
singly or in a group) or entity:
1. Agrees to follow all applicable
Federal, State, and local laws,
regulations, and policies.
2. Agrees to comply with all terms
and conditions of participation in this
Challenge.
3. Agrees that the submission will not
use HHS or AHRQ logos or official seals,
except as authorized by HHS or AHRQ.
Notwithstanding this authorized use of
AHRQ/HHS branding, participants will
not claim endorsement by AHRQ/HHS.
4. Understands that all materials
submitted to AHRQ as part of a
submission become AHRQ records. Any
confidential commercial or financial
information contained in a submission
must be clearly designated as such at
the time of submission.
5. Agrees that a winning submission
may only be announced by AHRQ and
in a time, place, and manner determined
by AHRQ in its sole discretion. Winners
will be permitted to publicize and
publish their winning submissions in
accordance with instructions provided
by AHRQ. The winner and runner-up
from Phase 2 will be posted on the
AHRQ website.
6. Agrees that the submission must
not infringe upon copyright or any other
rights of any third party.
7. Agrees to assume any and all risks
and waive claims against the Federal
Government and its related entities,
except in the case of willful misconduct,
for any injury, death, damage, or loss of
property, revenue, or profits, whether
direct, indirect, or consequential, arising
from participation in this prize contest,
whether the injury, death, damage, or
loss arises through negligence or
otherwise.
8. Agrees to indemnify the Federal
Government against third-party claims
E:\FR\FM\26SEN1.SGM
26SEN1
58353
Federal Register / Vol. 87, No. 185 / Monday, September 26, 2022 / Notices
for damages arising from or related to
Challenge activities.
9. Understands that circulation of
findings could be worldwide, and that
the Federal Government will not
compensate the participants for any use;
winners shall receive a one-time cash
prize as set forth in this announcement.
The winner and runner-up from Phase
2 will be posted on the AHRQ website.
10. Understands that AHRQ reserves
the right to cancel, suspend, and/or
modify this prize contest, or any part of
it, for any reason, in AHRQ’s sole
discretion. AHRQ also reserves the right
not to award any prizes if no entries are
deemed worthy.
11. Understands that AHRQ will not
select a winner that is named on the
Excluded Parties List System (EPLS).
Intellectual Property (IP) Rights
1. Each participant retains title and
full ownership in and to their
submission. Participants expressly
reserve all intellectual property rights
not expressly granted.
2. By participating in the Challenge,
each participant (whether participating
singly or in a group) acknowledges that
he or she is the sole author or owner of,
or has a right to use, any copyrightable
works that the submission comprises,
that the works are wholly original with
the participant (or is an improved
version of an existing work that the
participant has sufficient rights to use
and improve), and that the submission
does not infringe any copyright or any
other rights of any third party of which
participant is aware.
3. In addition, each participant
(whether participating singly or in a
group) grants to the U.S. Government a
paid-up, nonexclusive, royalty-free,
irrevocable worldwide license in
perpetuity, and the right to reproduce,
publish, post, link to, share, display
publicly (on the web or elsewhere) and
prepare derivative works, including the
right to authorize others to do so on
behalf of the U.S. Government.
4. Each participant must clearly
delineate any intellectual property and/
or confidential commercial information
contained in a submission that the
participant wishes to protect as
proprietary data, in accordance with
Additional Rules of Participation No. 4.
5. If the submission includes any
third-party works (such as third-party
content or open-source code), the
participant must be able to provide,
upon request, documentation of all
appropriate licenses and releases for use
of such third-party works. If the
participant cannot provide
documentation of all required licenses
and releases, AHRQ reserves the right,
in its sole discretion, to disqualify the
submission.
Dated: September 20, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–20703 Filed 9–23–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; ORR
Services for Survivors of Torture
Program Data Points and Performance
Progress Reports (New Collection)
Office of Refugee Resettlement,
Administration for Children and
Families, HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families’ (ACF) Office of
Refugee Resettlement (ORR) intends to
collect demographic, programmatic, and
outcome data on Services for Survivors
of Torture (SOT) grant recipients and
the clients they serve. This data
collection will allow ORR to learn more
about the populations served; the types
and effectiveness of services provided;
methods, challenges, and facilitators of
implementing services; and grant
recipients’ progress towards
programmatic goals. ORR will collect
these data on the new cohort of Services
for SOT grant recipients; ORR collected
information from the previous grantee
cohort under the Generic Performance
Progress Report (OMB #0970–0490).
ORR has made changes to the data
collection instruments for use in the
new cohort.
DATES: Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
SUMMARY:
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: ORR proposes to use the
Program Data Points Form (PDPs) and
Performance Progress Reports (PPRs) to
collect data on the Services for SOT
grant recipients and their clients. In
2019, ORR began requiring the Services
for SOT grant recipients to collect and
report their PDPs through the ORR
Refugee Arrivals Data System (RADS),
an information technology platform
used for enhanced data collection and
record keeping. The new cohort of
Services for SOT grant recipients, who
will receive 5-year awards in September
2022, will also provide these data points
to ORR using RADS. Grant recipients
will provide aggregated data on new and
continuing clients annually, including
demographic information,
characteristics related to experiences of
torture, services received, and wellbeing across six outcome domains.
Grant recipients will also provide
information about community
attendance at trainings and pro-bono
services donated to the program. In the
PPRs, grant recipients will provide
primarily narrative information on
grant-funded activities and progress
towards grant goals biannually.
Information collected will be used in
aggregate by ORR to provide reports to
stakeholders, including a required
report to Congress, and responses to
funding requests.
Respondents: Services for SOT grant
programs (this may include non-profit
social service, health, and higher
education organizations, states,
municipalities, and for-profit
organizations).
ADDRESSES:
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
Program Data Points Form (PDPs) .................................................................
VerDate Sep<11>2014
16:43 Sep 23, 2022
Jkt 256001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
35
E:\FR\FM\26SEN1.SGM
1
26SEN1
Average
burden hours
per response
6
Annual burden
hours
210
Agencies
[Federal Register Volume 87, Number 185 (Monday, September 26, 2022)]
[Notices]
[Pages 58350-58353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20703]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Challenge Competition: Announcement of AHRQ Challenge on
Integrating Healthcare System Data With Systematic Review Findings
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
announcing a challenge competition to explore the resources and
infrastructure needed to integrate real-world data from healthcare
systems into systematic review findings. This healthcare systems data
can augment study findings synthesized in systematic reviews in a
number of ways, including by filling evidence gaps identified in the
systematic review to strengthen the available evidence, and by
examining the applicability of systematic review findings to real-world
populations, including population subgroups not examined in published
studies. Ultimately, this work will help AHRQ understand if and how
sources of data and information outside of traditional systematic
reviews, particularly from healthcare systems themselves, could be used
alongside systematic reviews to improve healthcare decision making,
healthcare delivery and potentially patient outcomes. This challenge
competition will start on (September 26, 2022) and will be completed in
two phases, with cash prizes awarded at the end of Phase 2 to all of
those proceeding to Phase 2 and to the winners of Phase 2. The winner
and runner-up from Phase 2 will be posted on the AHRQ website.
DATES: Phase 1 Submission Deadline on January 9, 2023 and Phase 2
Submission Deadline on July 10, 2023.
ADDRESSES: Submit your responses electronically via: https://www.challenge.gov/?challenge=ahrq-challenge-on-integrating-healthcare-system-data-with-systematic-review-findings.
FOR FURTHER INFORMATION CONTACT: Suchitra Iyer, Director, Technology
Assessment Program; Email: [email protected], Telephone: 301-
427-1550.
SUPPLEMENTARY INFORMATION:
Problem Statement
The Agency for Healthcare Research and Quality (AHRQ), U.S.
Department of Health and Human Services (HHS), is announcing a
challenge competition to explore the feasibility, resources and
infrastructure needed to integrate real world data from healthcare
systems into systematic review findings. The statutory authority for
this challenge competition is Section 105 of the America COMPETES
Reauthorization Act of 2010.
AHRQ's Evidence-based Practice Center (EPC) Program produces
systematic reviews which synthesize information from the peer reviewed
literature and provide the state of the science on available healthcare
technologies (such as pharmaceuticals and medical devices) as well as
healthcare delivery strategies. The process of creating these reviews
is stakeholder driven, methodologically rigorous, and transparent.
Reviews are used to inform healthcare decisions, including
recommendations in clinical practice guidelines as well as national
coverage determinations by Medicare. AHRQ also supports healthcare
systems in their efforts to improve the quality of care and optimize
patient outcomes; systematic reviews are scoped to address issues of
priority to healthcare systems. Yet, due to limitations in the
literature base, EPC systematic reviews may be inconclusive or only
represent a narrow patient population, making it difficult to
generalize or implement the findings within heterogeneous healthcare
systems.
Systematic reviews may also lack contextual details that can inform
successful implementation. Improving healthcare delivery (and thus
patient outcomes) often entails addressing issues beyond the benefits
or harms of an intervention, traditionally the objective of a
systematic review. Traditional reviews may not explain gaps in uptake
or use of a clinical service and questions about how best to implement
a given clinical service (e.g., details around implementation of a
service or intervention).
A recent EPC Program methods report (https://effectivehealthcare.ahrq.gov/products/unpublished-health-data/methods-report) articulates specific scenarios with examples of where
healthcare system data may most effectively complement systematic
reviews (i.e., to improve the strength, applicability, and
implementation of evidence). In one example, investigators at the Mayo
Clinic found that published evidence on outcomes following total
pancreatectomy was sparse, so they supplemented a meta-analysis of
published studies with their own unpublished healthcare system data,
which more than doubled the sample size and improved the strength of
evidence available (https://pubmed.ncbi.nlm.nih.gov/20681992/).
In another instance, secondary analyses of Veterans Affairs (VA)
data (https://pubmed.ncbi.nlm.nih.gov/35810550/) confirmed the
applicability to the VA of findings from a published systematic review
(https://www.hsrd.research.va.gov/publications/esp/robot-gen-surg.cfm).
The recent EPC methods report also outlines important limitations
and considerations when using unpublished healthcare system data
alongside systematic reviews, such as relevant limitations in data
quality. However, the report did not address the necessary resources,
skills, partnerships, and processes required to utilize healthcare
system data alongside systematic reviews to strengthen the
actionability of systematic reviews.
This Challenge therefore invites applicants to conduct an analyses
of healthcare system data to supplement an existing AHRQ EPC Program
systematic review. This will help AHRQ understand if and how sources of
data
[[Page 58351]]
and information outside of traditional systematic reviews, particularly
from healthcare systems themselves, could be used alongside systematic
reviews to improve decision making, healthcare delivery, and
potentially patient outcomes.
Challenge Goal
The AHRQ EPC Program is interested in learning how analysis of
real-world data collected by healthcare systems can be used in
conjunction with findings from an AHRQ systematic review to inform
healthcare decision-making in the context of a specific local setting.
The goal of this challenge is to explore and determine the
feasibility, resources, and infrastructure needed to incorporate
unpublished healthcare system data into systematic review findings.
Ideally, these data will enable the healthcare system to make decisions
about which practices to incorporate locally and how to overcome
barriers to implement the evidence to improve clinical practice,
healthcare system operations and, potentially, health outcomes. The
winner and runner-up from Phase 2 will be posted on the AHRQ website.
Challenge Design
All evidence reports (systematic reviews, rapid reviews,
and technical briefs) published on the AHRQ website since January 2018
(https://effectivehealthcare.ahrq.gov/about) may be considered for this
Challenge.
Healthcare systems and other provider groups interested in
implementing evidence into practice at their sites may apply.
An organization may choose to address no more than 2
systematic reviews, submitting a separate proposal for each review.
Teams should have expertise in the clinical topic,
evidence-based practice, data analysis, and quality improvement.
This Challenge consists of two phases:
Phase 1: Proposal
Elicit written proposals on a topic for which an AHRQ evidence
report (systematic review, rapid review or technical brief) has been
published since January 2018 (https://effectivehealthcare.ahrq.gov/about) and that is relevant to a dilemma in the applicant's healthcare
system. Each proposal is to be written in the form of a narrative that:
1. Explicitly states the rationale (i.e., addressing evidence gaps
to strengthen available evidence, examining applicability of findings
to real-world patients) to complement findings from an EPC report with
analysis of health system data, including a discussion of possible
limitations of the analysis.
2. Develops and describes an analytic plan for use of healthcare
system data [EHR data from an individual healthcare system or networks
of healthcare systems (for example, PCORnet, Epic's Cosmos, etc.)].
3. Provides an approach for decision-making based on the results of
the data analysis and the evidence report, and an evaluation of the
decision-making process and results.
4. Describes potential challenges, barriers, and strategies to
successfully complete the analysis.
5. Lists team members, their role, area of expertise and hours on
project.
A total of 5 proposals will be selected as winners for Phase 1.
Phase 2: Analyses
Healthcare systems selected as winners in Phase 1 will be invited
to provide a written narrative that:
1. Includes a complete analysis of internal real-world data and
appraisal of the analysis for risk of bias using a formal tool such as
the ROBINS I (https://www.bmj.com/content/355/bmj.i4919).
2. Specifies how the findings from unpublished data support,
refute, and/or otherwise complement findings from the published
evidence examined in the systematic review. If the unpublished data
conflicts with the AHRQ review's conclusions, discuss possible reasons
for the discrepancy [e.g., challenges with internal validity of
healthcare system data analysis related to study design and methods
used, or challenges with external validity with respect to population
sub-groups (gender, race/ethnicity, multimorbidity) examined in the
healthcare system data].
3. Describes how the unpublished data informed decision-making
(e.g., adapt, adopt, abandon, prioritize).
4. Reports on solutions to any barriers encountered to using
healthcare system data alongside a published evidence review, including
barriers with access to healthcare system data, interoperability of
data sources, and data analysis.
5. Briefly describes potential approaches to implement or
deimplement the evidence, including use of clinical advisories,
clinical pathways, clinical decision support, or any other method. The
plan should describe anticipated risks and barriers and strategies for
successful implementation. Decisions made against uptake should be
justified.
Timeline and Prize Amounts
AHRQ is hosting this challenge as a two-phase competition. All
costs associated with developing and submitting proposals as well as
conducting the analysis of real-world data will be the responsibility
of the Challenge participant. Cash prizes will be awarded only after
the projects are evaluated and determined acceptable at the end of
Phase 2.
Timeline
September 26, 2022--Challenge launch.
January 9, 2023--Submissions for Phase 1 (written
proposals) are due. AHRQ will complete the review of the proposals
within 6-8 weeks of closing the announcement.
March 10, 2023--AHRQ will announce the Phase 1 winners.
Phase 2 of the Challenge will commence once the Phase 1 winners are
announced and notified by March 10, 2023. The AHRQ team will schedule a
live, virtual technical assistance webinar with all winners of Phase 1
to discuss scope of content, accessibility/compliance with Section 508,
and address questions that the winners may have.
March 10, 2023--Phase 2 participants will have at least
120 calendar days from notification to conduct and submit their
analyses as described in their proposal(s). The deadline to submit the
analysis is July 10, 2023.
Fall 2023--The final winners of Phase 2 of the competition
will be announced in October 2023.
Prize Amounts
The top five entries in phase one will be invited to participate in
Phase 2. Upon completion of Phase 2, each of the top five entries will
each receive cash awards of $50,000. Additionally, the first-place
winner from Phase 2 will be awarded an additional $150,000 and the
runner-up will be awarded an additional $100,000. The winner and
runner-up from Phase 2 will be posted on the AHRQ website.
How To Enter the Challenge
Participants can register by visiting the Challenge.gov website
(https://www.challenge.gov). Participants should carefully review
challenge information and submission requirements on the website,
including the intellectual property rules and assessment criteria.
Participants are encouraged to follow the Challenge on Challenge.gov to
obtain any updates and reminders of upcoming deadlines.
Submission Requirements
Phase 1
The submitted proposals must be written in US English and submitted
[[Page 58352]]
using Challenge.gov no later than January 9, 2023. Applicants or
applicant organizations shall submit no more than 2 proposals, and no
proposal shall describe more than one topic. Each proposal will be no
more than 2,000 words, double spaced, 11-point type size, with 1-inch
margins. Include in proposals plans for meeting Section 508
accessibility standards.
Phase 2
Analyses shall be a journal article-style written narrative in U.S.
English in no more than 4,000 words and submitted using the
Challenge.gov website no later than July 10, 2023.
Review Process
All submissions will be reviewed by at least two subject matter
experts from within or outside the federal government who will score
the proposals based on the assessment criteria and provide a brief
comment about the submission. The scores/comments on Phase 1 and Phase
2 submissions will be compiled, and a ranked summary provided to AHRQ
staff. AHRQ will select winners based on quantitative and qualitative
assessments.
Evaluation Criteria for Selecting Winning Applications
Assessment Criteria for Phase 1
1. Approach (40 points)
Does the proposal sufficiently describe:
a. the context and rationale for why the EPC report has been
chosen, and how the analyses of unpublished data will complement the
findings from the systematic review?
b. the data source and the analytic approach? Does the described
analytic approach provide the right balance of feasibility, rigor, and
innovation for the project?
2. Impact (40 points)
Does the proposal clearly and concisely describe:
a. potential routes for uptake of evidence within the healthcare
system?
b. method to measure whether the uptake will have an impact on
healthcare delivery, quality of care or patient outcomes?
c. anticipated risks, barriers, and strategies to successfully
complete the project?
3. Team (20 points)
Does the team have the right combination of expertise to support
the proposed technical approach?
Compliance (pass/fail)--Does the Phase 1 proposal adequately
address required accessibility standards (Section 508)?
Assessment Criteria for Phase 2
Participants in Phase 2 may be disqualified if their submitted
analyses deviate from their Phase 1winning proposals.
1. Analysis (40 points)
a. Are the description and discussion of the findings from the
analysis comprehensive?
b. To what degree is the alignment/nonalignment between healthcare
system data, the AHRQ systematic review, and the healthcare system's
decision-making explained?
2. Description of the Process (40 points)
a. Are the risks, barriers, challenges encountered, solutions, and
required infrastructure well described?
3. Future Plans (20 points)
a. Is the preliminary plan for implementation and evaluation
appropriate and feasible?
Compliance (pass/fail)--Does the Phase 1 proposal adequately
address required accessibility standards (Section 508)?
Eligibility Rules for Participating in the Challenge
To be eligible under this Challenge, an individual (whether
participating singly or in a group) or entity:
1. Shall have registered (Challenge.gov) to participate in the
Challenge.
2. Shall have complied with the rules set forth in this
announcement for participation in this Challenge.
3. Shall be incorporated and maintain a primary place of business
in the United States (in the case of a private entity), and in the case
of an individual, whether participating singly or in a group, shall be
a citizen or permanent resident of the United States.
4. May not be a Federal entity or Federal employee acting within
the scope of their employment. (All Federal employees should consult
with their agency Ethics Official to determine whether the federal
ethics rules will limit or prohibit the acceptance of a prize).
5. May not be an employee of AHRQ or any other company,
organization, or individual involved with the design, production,
execution, judging, or distribution of the Challenge, or their
immediate family (spouse, parents and step-parents, siblings and step-
siblings, and children and step-children), or household members (people
who share the same residence at least 3 months out of the year).
6. May not use Federal funds from a grant to develop Challenge
applications unless consistent with the purpose of the grant award.
7. May not use Federal funds from a contract to develop Challenge
applications or to fund efforts in support of a Challenge submission.
8. Shall not be deemed ineligible because the individual or entity
used Federal facilities or consulted with Federal employees during a
competition if the facilities and employees are made equitably
available to all individuals and entities participating in the
competition.
9. Shall not be required to purchase liability insurance as a
condition of participation in this competition.
Additional Rules of Participation
By participating in this Challenge, each individual (whether
participating singly or in a group) or entity:
1. Agrees to follow all applicable Federal, State, and local laws,
regulations, and policies.
2. Agrees to comply with all terms and conditions of participation
in this Challenge.
3. Agrees that the submission will not use HHS or AHRQ logos or
official seals, except as authorized by HHS or AHRQ. Notwithstanding
this authorized use of AHRQ/HHS branding, participants will not claim
endorsement by AHRQ/HHS.
4. Understands that all materials submitted to AHRQ as part of a
submission become AHRQ records. Any confidential commercial or
financial information contained in a submission must be clearly
designated as such at the time of submission.
5. Agrees that a winning submission may only be announced by AHRQ
and in a time, place, and manner determined by AHRQ in its sole
discretion. Winners will be permitted to publicize and publish their
winning submissions in accordance with instructions provided by AHRQ.
The winner and runner-up from Phase 2 will be posted on the AHRQ
website.
6. Agrees that the submission must not infringe upon copyright or
any other rights of any third party.
7. Agrees to assume any and all risks and waive claims against the
Federal Government and its related entities, except in the case of
willful misconduct, for any injury, death, damage, or loss of property,
revenue, or profits, whether direct, indirect, or consequential,
arising from participation in this prize contest, whether the injury,
death, damage, or loss arises through negligence or otherwise.
8. Agrees to indemnify the Federal Government against third-party
claims
[[Page 58353]]
for damages arising from or related to Challenge activities.
9. Understands that circulation of findings could be worldwide, and
that the Federal Government will not compensate the participants for
any use; winners shall receive a one-time cash prize as set forth in
this announcement. The winner and runner-up from Phase 2 will be posted
on the AHRQ website.
10. Understands that AHRQ reserves the right to cancel, suspend,
and/or modify this prize contest, or any part of it, for any reason, in
AHRQ's sole discretion. AHRQ also reserves the right not to award any
prizes if no entries are deemed worthy.
11. Understands that AHRQ will not select a winner that is named on
the Excluded Parties List System (EPLS).
Intellectual Property (IP) Rights
1. Each participant retains title and full ownership in and to
their submission. Participants expressly reserve all intellectual
property rights not expressly granted.
2. By participating in the Challenge, each participant (whether
participating singly or in a group) acknowledges that he or she is the
sole author or owner of, or has a right to use, any copyrightable works
that the submission comprises, that the works are wholly original with
the participant (or is an improved version of an existing work that the
participant has sufficient rights to use and improve), and that the
submission does not infringe any copyright or any other rights of any
third party of which participant is aware.
3. In addition, each participant (whether participating singly or
in a group) grants to the U.S. Government a paid-up, nonexclusive,
royalty-free, irrevocable worldwide license in perpetuity, and the
right to reproduce, publish, post, link to, share, display publicly (on
the web or elsewhere) and prepare derivative works, including the right
to authorize others to do so on behalf of the U.S. Government.
4. Each participant must clearly delineate any intellectual
property and/or confidential commercial information contained in a
submission that the participant wishes to protect as proprietary data,
in accordance with Additional Rules of Participation No. 4.
5. If the submission includes any third-party works (such as third-
party content or open-source code), the participant must be able to
provide, upon request, documentation of all appropriate licenses and
releases for use of such third-party works. If the participant cannot
provide documentation of all required licenses and releases, AHRQ
reserves the right, in its sole discretion, to disqualify the
submission.
Dated: September 20, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022-20703 Filed 9-23-22; 8:45 am]
BILLING CODE 4160-90-P